This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Novo Nordisk A/S

Drug Names(s): long-acting rFVIII derivative, rFVIII glycopegylated, NN7088, NNC 0129-0000-1003

Description: NN7088 is a glyco-PEGylated derivative of recombinant factor VIII. In the coagulation cascade, factor VIII acts as a cofactor for factor IXa in the activation of factor X.

N8-GP News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug